Lily Baricitinib

  • What's involved: A randomised active controlled parallel-group phase 3/4 study Baricitinib in patients with RA
  • Take part: Open
  • Principal Investigator: Professor David Walsh
Research Theme | Musculoskeletal | Open Trials

What's involved

A randomised active controlled parallel-group phase 3/4 study Baricitinib in patients with RA

Principal Investigator

Professor David Walsh

Take part

Open
Back to all trials

Contact Us

NIHR Biomedical Research Centre: Nottingham
Research & Innovation
D Floor (via South Block)
Nottingham University Hospitals NHS Trust
Queen’s Medical Centre
Derby Road
Nottingham
NG7 2UH

Telephone: 0115 924 9924

Director: Professor Ian Hall

Hosted by

Nottingham University Hospitals Logo

Nottingham University Hospitals Logo

We are a partnership between Nottingham University Hospitals NHS Trust and the University of Nottingham, supported by NHS and academic partners in Nottingham and across the East Midlands.

Website by Volute